Source: Med-Cannabis Pharma, Inc. Press Release

CARROLLTON, TX / ACCESSWIRE / January 29, 2015 / Med-Cannabis Pharma, Inc. (MCPI) a public company invested in medical marijuana cultivation and retail distribution applauds the recent decision of the U.S. Security and Exchange Commission. In a move that could bolster investor confidence in businesses engaged in the emerging and growing Legal Marijuana Industry, the U.S. Securities and Exchange Commission has allowed a share registration to proceed for Terra Tech Corp. (TRTC) The revelatory aspect of this registration is that the company’s business model includes cultivation and sale of marijuana. The ease in which this was accomplished, and apparent lack of pushback or action by the SEC could allow similarly situated companies access to the equity market and be seen as a precedent in future registrations of businesses in the legal marijuana industry.

“The decision opens up exciting possibilities for MCPI and offers additional opportunities for investor involvement in such a booming industry,” said Graciela Moreno, CEO of Med-Cannabis Pharma, Inc. “We will continue to be aggressive and grow as we explore, expand, and capitalize on positive policy outcomes such as this.”

MCPI, as most other cannabis related-companies in this emerging market, trades over-the-counter. An SEC registration can open opportunities to these companies for additional financing and adds to the credibility of the companies in this industry. Already, MCPI has shown a strong track record of acquiring and partnering with other medical marijuana operators with the recent purchases of two operating dispensaries, building lease space for another, and beginning a joint venture with Royal Tree Organics on a grow facility. The success of Terra Tech Corp’s. registration with the SEC for listing on a major stock exchange is a positive indicator that could bolster investor confidence in emerging companies by providing a valid avenue for growth without the fear of regulatory obstacles.

Forward Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. The Company does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Contact Information

Med-Cannabis Pharma, Inc.
+1 214-666-8364 direct

SOURCE: Med-Cannabis Pharma, Inc.